In addition, there are some factors with the moderate expression, such as PDGF‐AA, ALCAM, FGF7, IGFBP6, FASLG, etc; although their expression intensity is relatively low, their roles in hUC‐MSC‐treatment of AD also need to be explored. This evidence concerns the gene FGF7 and Alzheimer disease.